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To the Editor
The role of advanced glycation end products (AGEs)
in the pathophysiology of diabetes-related complica-
tions and aging has been studied extensively. The AGEs
represent chronic exposure to hyperglycemia and oxida-
tive stress. Tissue AGE accumulation can be assessed
non-invasively by measuring skin autoﬂuorescence
(SAF) with a so-called AGE reader. Markers of oxida-
tive stress are elevated during pregnancy, which can, in
turn, increase the formation of AGEs.1 One study
reported that SAF levels were higher in pregnant
women with pre-existing diabetes than in women with
gestational diabetes and women without diabetes.2
Preliminary data from our group suggested that SAF
increases during pregnancy and does not return to pre-
pregnancy levels (B. Groen et al., unpublished data,
2014). This phenomenon may be caused by increased
oxidative and glycemic stress during pregnancy. There-
fore, the aim of the present study was to assess the rela-
tionship between SAF and the number of pregnancies.
Methods
Subjects included in the study were participants from the
Lifelines Cohort Study, a large population-based cohort
study in the northern region of the Netherlands (www.
lifelines.net, accessed 24 December 2017). The Lifelines
study was approved by the Medical Ethics Committee of
the University Medical Center Groningen. Written
informed consent was obtained from all participants.
The present study included women of Western European
descent aged between 18 and 80 years for whom an SAF
measurement was available. Subjects with type 1 and
type 2 diabetes were excluded, as were as those with
missing data for diabetes, leaving 47 834 individuals for
analysis. Subjects completed a questionnaire on medical
history, past and current diseases, use of medication, and
health behavior. The questionnaire also included infor-
mation on previous pregnancies and childbirth. Women
were asked how many times they had been pregnant and
how many children were born. In the present study, SAF
was calculated as the mean of three consecutive
measurements using an AGE Reader (DiagnOptics
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• Skin autoﬂuorescence (SAF) assesses subcutaneous accumulation of advanced glycation end products and has
been shown to predict future cardiovascular disease and diabetes.
• A higher number of pregnancies was signiﬁcantly associated with higher SAF, even after correction for relevant
confounders like waist circumference, creatinine clearance, and diabetes status, but not after correction for age.
• Women with the highest SAF Z-score had a more unfavorable risk factor proﬁle, with higher body mass index
and waist circumference, higher blood pressure, lower high-density lipoprotein cholesterol, and higher triglycer-
ide levels.
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Technologies, Groningen, Netherlands).3 Age-adjusted
SAF (Z-scores) was calculated because SAF is strongly
affected by aging.3
Data are given as the mean SD or as the median with
interquartile range (IQR) in the case of non-normally
distributed data. Linear regression analysis was per-
formed to examine the association between the number
of pregnancies and SAF. In the multivariate models, we
adjusted for relevant factors, such as waist circumference,
body mass index (BMI), renal function, and smoking.
Two-tailed P < 0.001 was considered signiﬁcant.
Results
The clinical characteristics of the study population are
given in Table S1, available as Supplementary Material
to this paper. Mean subject age was 44 12 years,
mean waist circumference was 87 12 cm, and mean
BMI was 25.8 4.6 kg/m2. The median number of
pregnancies was 2.0 (IQR 1.0–3.0). In total, 20.5% of
women had not been pregnant, 42% reported one to
two pregnancies, 30% reported three to four pregnan-
cies, and 7.5% reported ﬁve or more pregnancies. A
higher number of pregnancies was associated with
higher SAF, which persisted after correction for waist
circumference and renal function (P < 0.0001). How-
ever, after further correction for age, SAF was no lon-
ger associated with the number of pregnancies
(P = 0.713; Table 1). Fig. 1 shows that SAF Z-scores
are comparable in the various groups of women divided
according to the number of pregnancies. Women in the
highest quartile of the SAF Z-score had a higher preva-
lence of metabolic syndrome, as well as higher BMI,
waist circumference, glucose, HbA1c, and lipids (all
P < 0.01) than women in the other three quartiles, and
a similar number of pregnancies compared with those
in the lowest quartile (Table S2).
Discussion
After correction for important confounders, SAF
increased with the number of pregnancies in women
from the general population. However, after correction
for age, this association was no longer signiﬁcant. The
increased oxidative stress that occurs during pregnancy
may signiﬁcantly affect SAF measurements. Indeed, it
has been reported that SAF is elevated in women with
pre-eclampsia and associated with increased carotid
artery intima–media thickness, a marker for atheroscle-
rosis.4 Moreover, SAF was associated with higher
blood pressure, triglycerides, and C-reactive protein
levels, indicating the potential cardiovascular risk asso-
ciated with these factors.5 Therefore, we postulate that
the effect of pregnancy on SAF may only be restricted
to pathological pregnancies, such as those complicated
by pre-eclampsia.4,5 Unfortunately, the Lifelines dataset
did not record any complications of pregnancy.
Two important studies have reported on the associa-
tion between reproductive history and cardiovascular
health. One of these studies reported that a higher num-
ber of pregnancies was associated with lower cardiovascu-
lar mortality,6 whereas the other study showed that the
Table 1 Univariate and multivariate analyses for skin
autoﬂuorescence
Model Parameters β P-value R2 (%)
1 No. pregnancies 0.061 <0.0001 5.3
2 No. pregnancies 0.0003 0.800 30.7
Age 0.020 <0.0001
3 No. pregnancies 0.0031 <0.0001 19.7
Waist 0.013 <0.0001
GFR −0.006 <0.0001
4 No. pregnancies 0.030 <0.0001 20.5
Waist 0.012 <0.0001
GFR −0.006 <0.0001
Diabetes or glucose 0.084 <0.0001


























Figure 1 Number of pregnancies and age-corrected skin autoﬂuor-
escence (SAF) Z-score. The boxes show the interquartile range, with
the median value indicated by the horizontal line; whiskers show
the range. Dots indicate outliers.
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number of pregnancies or live births was associated with
higher left ventricular mass and end-systolic volume.7 A
recent review suggested that pre-eclampsia is an under-
recognized risk factor for ischemic heart disease, chronic
hypertension, peripheral vascular disease, and stroke.8
In conclusion, in the present study SAF increased
with a higher number of pregnancies, but not after
correction for participants’ age. Those with the highest
age-corrected SAF had a worse risk factor proﬁle for
future cardiovascular disease.
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